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Background
During chronic HIV-1 infection, upregulation in the expression of certain negative regulatory factors has been implicated recently as a cause of defects in dendritic cells (DCs). We aim to study the association of one such factor, the suppressor of cytokine signaling-1 (SOCS-1) gene with DC dysfunction during HIV-1 infection.
Methods
DCs from 21 therapy naïve (mean CD4: 256 cells/mm 3 ), 21 patients on anti-retroviral therapy (mean CD4: 342 cells/mm 3 ) and 14 healthy controls were immunophenotyped for maturation markers at baseline and after 5 hour ex vivo stimulation with TLR-4 ligand, LPS, by flowcytometry. Subsequently, the expression of SOCS-1 gene and the cytokine levels were assessed in monocytederived DCs (Mo-DC) of healthy donors exposed to LPS and HIV-1 gp120 by real time PCR and flowcytometry respectively.
Results
The myeloid DCs of untreated subjects had significantly lower responsiveness to LPS stimulation as indicated by lower upregulation of CD83 (mean±SE: 31±4.4 vs. 50±3) and CD80 (30±4 vs. 40±3) as compared to healthy controls. Treated patients had a higher upregulation of CD83 (mean±SE: 38±4) and CD80 (mean±SE: 33±3) though not significantly higher than untreated patients. The expression of SOCS-1 was higher upon exposure to HIV-1 gp120 than LPS in 5 healthy controls assessed and their culture supernatants showed decreased levels of all the cytokines, mainly IL-6 and TNF-α.
Conclusions
Therapy naïve patients exhibit deficient DC maturation upon LPS stimulation, which is partially restored following antiretroviral treatment. An increased expression of SOCS-1 gene upon gp120 exposure suggests a possible role of SOCS-1 in DC impairment. 
